CD19 and acute lymphoblastic leukemia: While early CD19 CAR-T cell clinical trials primarily enrolled R/R adult patients, a groundbreaking milestone was achieved in 2012 when physicians and scientists from CHOP administered CD19 CAR-T therapy to the first pediatric patient with B-ALL.